To meet increasing global demand for cell culture media used in the manufacturing of new vaccines and biologics, Thermo Fisher Scientific has expanded its dry powder media manufacturing facility in Grand Island, New York. With this expansion, the Grand Island site provides redundant capacity to support global .
Ion Torrent Oncomine Myeloid MRD Assays (RUO) are the first NGS-based tests to offer simultaneous DNA and RNA analysis for myeloid MRD assessmentCARLSBAD, Calif. (BUSINESS WIRE) Thermo Fisher Scientific today launched a next-generation sequencing (NGS)-based assay for research in myeloid measurable residual diseas.
Marking its 20th global recipient, the grant program supports next-generation sequencing-based research to explore new and expanded applications for molecular testingCARLSBAD, Calif. (BUSINESS WIRE) As part of its continued commitment to expand the benefits of next-generation sequencing (NGS), Thermo Fisher Scient.
Thermo Fisher Scientific Inc., the world leader in serving science, is showcasing innovative diagnostic technologies, assays and a complement of solutions for researchers developing new diagnostics. During the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory .